Adam Pascale

2017

In 2017, Adam Pascale earned a total compensation of $295.4K as CFO at Hemispherx Biopharma, a 25% increase compared to previous year.

Compensation breakdown

Option Awards$12,501
Salary$234,500
Other$48,379
Total$295,380

Pascale received $234.5K in salary, accounting for 79% of the total pay in 2017.

Pascale also received $12.5K in option awards and $48.4K in other compensation.

Rankings

In 2017, Adam Pascale's compensation ranked 13,377th out of 14,666 executives tracked by ExecPay. In other words, Pascale earned more than 8.8% of executives.

ClassificationRankingPercentile
All
13,377
out of 14,666
9th
Division
Manufacturing
5,256
out of 5,768
9th
Major group
Chemicals And Allied Products
1,900
out of 2,074
8th
Industry group
Drugs
1,584
out of 1,730
8th
Industry
Biological Products, Except Diagnostic Substances
293
out of 316
7th
Source: SEC filing on August 3, 2018.

Pascale's colleagues

We found two more compensation records of executives who worked with Adam Pascale at Hemispherx Biopharma in 2017.

2017

Thomas Equels

Hemispherx Biopharma

Chief Executive Officer

2017

Peter Rodino

Hemispherx Biopharma

General Counsel

News

You may also like